CoChat

Overview of the use of CoQ10 in cardiovascular disease

Langsjoen, Peter H., Langsjoen, Alena M. · 1999 · BioFactors
Cited by 147

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The clinical experience in cardiology with CoQ 10 includes studies on congestive heart failure, ischemic heart disease, hypertensive heart disease, diastolic dysfunction of the left ventricle, and reperfusion injury as it relates to coronary artery bypass graft surgery. The CoQ 10‐lowering effect of HMG‐CoA reductase inhibitors and the potential adverse consequences are of growing concern. Supplemental CoQ 10 alters the natural history of cardiovascular illnesses and has the potential for prevention of cardiovascular disease through the inhibition of LDL cholesterol oxidation and by the maintenance of optimal cellular and mitochondrial function throughout the ravages of time and internal and external stresses. The attainment of higher blood levels of CoQ 10 (>3.5 μg/ml) with the use of higher doses of CoQ 10 appears to enhance both the magnitude and rate of clinical improvement. In this communication, 34 controlled trials and several open‐label and long‐term studies on the clinical effects of CoQ 10 in cardiovascular diseases are reviewed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biof.5520090224

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Langsjoen, P. H., & Langsjoen, A. M.
Venue
BioFactors
Publisher
Wiley
Published
1999-01
Volume
9
Issue
2-4
Pages
273-284
ISSN
  • 0951-6433 (ISSN-L)
  • 1872-8081
OpenAlex
W1810099991
Cited by
147
References
3
FWCI
1.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.